Patients who have received radiation within  days before the first dose of study treatment
The subject has received therapeutic radiation:\r\n* To the bladder/prostate/rectum pelvis\r\n* To any other site(s) within  days of the first dose of study treatment
The subject has received radiation therapy as follows: \r\n* To the thoracic cavity, abdomen or pelvis within  months of the first dose of study treatment or has with ongoing complications or is without complete recovery and healing from prior radiation therapy\r\n* To bone or brain metastasis within  days of the first dose of study treatment\r\n* To any other site(s) within  days of the first dose of study treatment
The subject has received radiation therapy:\r\n* To the thoracic cavity, abdomen or pelvis within  months of the first dose of study treatment that has with ongoing complications or is without complete recovery and healing from prior radiation therapy (CT changes related to radiation treatment which are not clinical significant are allowed)\r\n* To bone or brain metastasis within  days of the first dose of study treatment\r\n* To any other site(s) within  days of the first dose of study treatment
The subject has received radiation therapy:\r\n* To bone metastasis within  days before the first dose of study treatment \r\n* To any other site(s) within  days before the first dose of study treatment
The subject has received radiation therapy:\r\n* To the thoracic cavity or gastrointestinal tract within  months of the first dose of study treatment\r\n* To bone or brain metastasis within  days of the first dose of study treatment\r\n* To any other site(s) within  days of the first dose of study treatment
No prior radiation therapy within the last  weeks, except as below \r\n* To the thoracic cavity, abdomen, or pelvis within  weeks before the first dose of study treatment, or has ongoing complications, or is without complete recovery to < grade  toxicity\r\n* To bone or brain metastasis within  days before the first dose of study treatment\r\n* To any other site(s) within  days before the first dose of study treatment\r\n* Prior radiation treatment may have included no more than  centigray (cGy) to fields including substantial bone marrow
Radiation therapy:\r\n* To the thoracic cavity, abdomen or pelvis within  months of the first dose of study treatment or has ongoing complications or is without complete recovery and healing from prior radiation therapy\r\n* To bone metastases within  days of the first dose of study treatment\r\n* To any other site(s) within  days of the first dose of study treatment
The subject has received radiation therapy:\r\n* To the thoracic cavity or gastrointestinal tract within  months before the first dose of study treatment\r\n* To brain metastasis within  days before the first dose of study treatment\r\n* To any other site(s), with the exception of bone, within  days before the first dose of study treatment
The subject has received radiation therapy:\r\n* To bone or brain metastasis within  days of the first dose of study treatment\r\n* To any other site(s) within  days of the first dose of study treatment
The subject has received radiation therapy:\r\n* To the thoracic cavity or gastrointestinal tract within  months before the first dose of study treatment\r\n* To bone or brain metastasis within  days before the first dose of study treatment\r\n* To any other site(s) within  days before the first dose of study treatment
The participant has received radiation therapy:\r\n* To the thoracic cavity or gastrointestinal tract within  months of the first dose of study treatment\r\n* To bone or brain metastasis within  days of the first dose of study treatment\r\n* To any other site(s) within  days of the first dose of study treatment
The subject has received radiation therapy:\r\n* To the thoracic cavity or gastrointestinal tract within  months of the first dose of study treatment\r\n* To bone or brain metastasis within  days of the first dose of study treatment\r\n* To any other site(s) within  days of the first dose of study treatment
The subject has received radiation therapy:\r\n* To the thoracic cavity or abdomen within  months before the first dose of study treatment, or has ongoing complications, or is without complete recovery and healing from prior radiation therapy\r\n* To bone or brain metastasis within  weeks before the first dose of study treatment\r\n* To any other site(s) within  days before the first dose of study treatment
The subject has received radiation therapy:\r\n* To the thoracic cavity, abdomen or pelvis within  months of the first dose of study treatment or has with ongoing complications or is without complete recovery and healing from prior radiation therapy\r\n* To bone or brain metastasis within  days of the first dose of study treatment
The subject has received radiation therapy within  days of the first dose of study treatment
